This inventor holds 1 USPTO granted patent. Top assignees: Tel Aviv University, Tel Hashomer Medical Research Infrastructure and Services Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: Shimrit Adutler-Lieber: Innovator in Nanoparticle Technology
Introduction
Shimrit Adutler-Lieber is a notable inventor based in Bat Yam, Israel. She has made significant contributions to the field of nanotechnology, particularly in the development of iron oxide nanoparticles for medical applications. Her work focuses on innovative solutions for treating non-infectious inflammatory disorders.
Latest Patents
Shimrit Adutler-Lieber holds a patent for "Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders." This patent outlines the use of iron oxide nanoparticles in the treatment of such disorders, along with methods of treatment, pharmaceutical compositions, and kits that incorporate these particles. This innovation represents a promising advancement in therapeutic options for patients suffering from inflammatory conditions.
Career Highlights
Throughout her career, Shimrit has been associated with prestigious institutions such as Tel Aviv University and Tel Hashomer Medical Research Infrastructure and Services Ltd. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Shimrit has worked alongside talented colleagues, including Yifat Glucksam-Galnoy and Tamar Ben-Mordechai. These collaborations have fostered a dynamic research environment, enhancing the development of innovative solutions in her area of expertise.
Conclusion
Shimrit Adutler-Lieber's contributions to the field of nanotechnology and her innovative patent for iron oxide nanoparticles highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of non-infectious inflammatory disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile